AML in an older adult: discussing treatment intensity

For an older adult with acute myeloid leukaemia, “intensive” and “less intensive” describe approaches that need explanation in the context of the individual. The right discussion includes the disease findings, other illnesses, everyday function, support and the person’s priorities. Age alone is not a complete clinical assessment.

Clarify what each approach is intended to achieve

The NHS describes intensive and non-intensive AML treatment options and explains that selection depends on circumstances including overall health. Ask the haematologist to state the goal of the proposed route and the burdens it may involve. A less intensive schedule can still require close monitoring and urgent support; the phrase does not mean there are no important risks.

Ask whether the options being compared have the same objective. A proposal designed to seek remission and a proposal mainly focused on controlling symptoms should not be compared as though they were simply different prices for the same service.

Describe function before and during the illness

Tell the team what the patient could do before becoming unwell and what has changed now. Describe walking, eating, managing medicines and ordinary self-care in concrete terms. Include hearing, memory or communication needs and the help available at home.

This information complements medical tests; it is not a family-administered eligibility score. A temporary decline during an acute illness should be described as such rather than silently treated as the person’s usual level of function.

Bring priorities into the treatment conversation

• What benefit is the proposed treatment aiming for, and what uncertainty remains?
• How much time may need to be spent in hospital or near the centre?
• What support is required between visits?
• How will tolerability and response be reassessed?
• What happens if the burdens become unacceptable to the patient?

The patient should be included as fully as possible. An interpreter or hearing support may make a larger difference to informed participation than a longer appointment without appropriate communication help.

Compare recommendations using the same facts

If requesting a second opinion in Turkey, send the current AML findings, medicine list, organ assessments and a short description of function and goals. Ask the reviewing specialist to explain any disagreement with the current plan. Avoid choosing by a hospital’s age-limit slogan or assuming that a more intensive plan is automatically more suitable.

Discuss whether travel itself adds a burden that changes the practical choice. If care is to be shared across countries, identify who arranges laboratory checks, prescribed transfusions, medicine supply and urgent assessment. Family availability should be described realistically.

Request a quotation for the proposed period and setting of care, including support and follow-up assumptions. The decision should rest on an explained medical recommendation and the patient’s preferences, with continuing review as the situation changes. This guide cannot determine the treatment intensity appropriate for an individual.

Compare an ordinary treatment week, not only the first admission

Ask the team to describe the practical week expected with each reasonable option: visits, travel, possible time near the hospital and help with ordinary tasks. Have the family state who can actually provide that help. An outpatient plan may still be difficult for someone who cannot reliably get to appointments or manage changes to several prescriptions. These limitations should be discussed before they appear as missed care.

Then ask the patient which burdens matter most and which trade-offs they would consider acceptable. A preference to remain close to family, or to preserve a particular daily activity, should be heard alongside the clinical assessment. Record that preference in the second-opinion request so that both doctors are answering the same question. If goals change during treatment, the plan can be discussed again with the treating team; a decision made at the first visit should not prevent a later conversation about what the patient now wants.

A practical next step

For the practical arrangements, see An oncology second opinion: when it helps and how to prepare.

Sources

• NHS: Acute Myeloid Leukaemia Treatment